Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000094.xml
Z Gastroenterol 2003; 41(7): 675-678
DOI: 10.1055/s-2003-40546
DOI: 10.1055/s-2003-40546
Kommentiertes Referat
© Karl Demeter Verlag im Georg Thieme Verlag Stuttgart · New York
Verbessert die Überwachung von Patienten mit Barrett-Ösophagus das Überleben?
Does Surveillance of Patients with Barrett’s Esophagus Improve Survival?Further Information
Publication History
Publication Date:
14 July 2003 (online)
Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and Survival in Barrett’s adenocarcinomas: a population based study. Gastroenterology 2002; 122: 633-640
Literatur
- 1 Lagergren J, Bergstrom R, Lindgren A. et al . Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999; 340 825-831
- 2 Cameron A, Lomboy C. Barrett’s esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992; 103 1241-1245
- 3 Bonelli L. Barrett’s esophagus: results of a multicenter survey. Endoscopy. 1993; 25 (suppl) 652-654
- 4 Robinson M, Earnest D, Rodriguez-Stanley S. et al . Heartburn requiring frequent antacid use may indicate significant illness. Arch Intern Med. 1998; 158 2373-2376
- 5 Gerson L, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology. 2002; 123 461-467
- 6 Shaheen N, Crosby M, Bozymski E. et al . Is there a publication bias in the reporting of cancer risk in Barrett’s esophagus?. Gastroenterology. 2000; 119 333-338
- 7 Blot W, McLaughlin J. The changing epidemiology of esophageal cancer. Semin Oncol. 1999; 26 (suppl 15) 2-8
- 8 Sabik J, Rice T, Goldblum J. et al . Superficial esophageal carcinoma. Ann Thorac Surg. 1995; 60 896-902
- 9 Sampliner R. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 2002; 97 1888-1895
- 10 Sonnenberg A, Soni A, Sampliner R. Medical decision analysis of endoscopic surveillance of Barrett’s oesophagus to prevent oesophageal adenocarcinoma. Aliment Pharmacol Ther. 2002; 16 41-50
- 11 Wright T, Gray M, Morris A. et al . Cost effectiveness of detecting Barrett’s cancer. Gut. 1996; 39 574-579
- 12 Van Sandick J, Lanschot J v, Kuiken B. et al . Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma. Gut. 1998; 43 216-222
- 13 Bani-Hani K, Sue-Ling H, Johnston D. et al . Barrett’s oesophagus: results from a 13-year surveillance programme. Eur J Gastroenterol Hepatol. 2000; 12 649-654
- 14 Thomas P, Doddoli C, Lienne P. et al . Changing patterns and surgical results in adenocarcinoma of the oesophagus. Br J Surg. 1997; 84 119-125
- 15 Sackett D. Bias in analytic research. J Chronic Dis. 1979; 32 51-63
- 16 Dulai G. Surveying the case for surveillance. Gastroenterology. 2002; 122 820-825
- 17 Dulai G, Guha S, Kahn K. et al . Preoperative prevalence of Barrett’s esophagus in esophageal adenocarcinoma: a systematic review. Gastroenterology. 2002; 122 26-33
- 18 Provenzale D, Schmitt C, Wong J. Barrett’s esophagus: A new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol. 1999; 94 2043-2053
- 19 Endlicher E, Ruemmele P, Beer S. et al . Endoscopic and histologic diagnosis of Long- and Short-Barrett’s esophagus. Gastrointest Endosc. 2002; 55 AB203
- 20 Cameron A, Kamath P, Carpenter H. Barrett’s esophagus: The prevalence of short and long segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Gastroenterology. 1995; 91 A65
- 21 Ott R, Roesch TJM, Birkner B. et al . Much ado about the „ultrashort” Barrett esophagus? Results from the munich multicenter study. Gastroenterology. 1999; 116 A275
- 22 Weston A, Krmpotich P, Makdisi W. et al . Short segment Barrett’s esophagus: Clinical and histological features, associated endoscopic findings, and association with gastric intestinal metaplasia. Am J Gastroenterol. 1996; 91 981-986
- 23 Winters C J, Spurling T, Chobanian S. et al . Barrett’s esophagus: a prevalent occult complication of gastroesophageal reflux disease. Gastroenterology. 1987; 92 118-124
- 24 Eloubeidi M, Provenzale D. Does this patient have Barrett’s esophagus? The Utility of predicting Barrett’s esophagus at the index endoscopy. Am J Gastroenterol. 1999; 94 937-943
- 25 Seitz G, Vieth M, Stolte M. Does endoscopically negative Barrett’s mucosa really exist?. Gastrointest Endosc. 2002; 55 AB203
- 26 Weinstein W, Leh W, Lewin K. et al . How often is short segement Barrett’s esophagus proven histologically? A prospective study. Gastroenterology. 2002; 122 (suppl) A293
- 27 Voutilainen M, Färkkilä M, Juhola M. et al . Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. Am J Gastroenterol. 1999; 94 913-918
- 28 Nandurkar S, Talley N, Martin C. et al . Short segment Barrett’s oesophagus: prevalence, diagnosis and associations. Gut. 1997; 40 710-715
- 29 Canto M, Setrakian S, Willis J. et al . Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gastrointest Endosc. 2000; 51 560-568
Dr. E. Endlicher
Klinik und Poliklinik für Innere Medizin I, Klinikum der Universität Regensburg
93042 Regensburg
Email: esther.endlicher@klinik.uni-regensburg.de